BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI“ or the “Company“) (Nasdaq: ANIP) today announced that ANI's Board of Directors granted non-qualified inducement stock options to ...
On Tuesday, 20 May 2025, ANI Pharmaceuticals (NASDAQ:ANIP) presented at the H.C. Wainwright 3rd Annual BioConnect Investor Conference 2025. The company emphasized its strategic focus on expanding its ...
H.C. Wainwright’s price target increase was attributed to upward earnings revisions following ANI’s commercial execution and enhanced cash flow generating capacity. While the company shows strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results